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Abstract Obesity is a leading risk factor for impaired
glucose tolerance and type 2 diabetes (T2D). Although the
cause of the obesity epidemic is multi-factorial and not
entirely clear, the recent acceleration in incidence is too
rapid to be accounted for only by genetics, the wide
availability of calorie-rich foods, and increasingly seden-
tary lifestyles. Accumulating data suggest that the impor-
tant causes of the obesity epidemic may be related to
developmental and early life environmental conditions.
The concept of the developmental origins of health and
disease (DOHaD) suggests that adverse influences early in
development, particularly during intrauterine life, may
result in permanent changes in the physiology and metab-
olism of the infant, which in turn result in an increased risk
of non-communicable diseases in adulthood. For example,
undernutrition during pregnancy and rapid postnatal weight
gain are associated with obesity and T2D in the adult
offspring. Moreover, increasing evidence suggests that
early-life exposure to a wide range of chemicals has a
significant impact on the causes of metabolic disorders.
Although the underlying molecular mechanisms remain to
be determined, these factors can affect epigenetic pro-
cesses, such as DNA methylation, allowing the develop-
mental environment to modulate gene transcription. The
objective of this review article was to summarize recent
progress in the biomedical implications of the DOHaD
concept, focusing on the pathogenesis of obesity and T2D,
and to discuss a future direction for preventive strategies
from a public health perspective.
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Abbreviations
BMI Body mass index
BPA Bisphenol A
DDE Dichlorodiphenyl-dichloroethylene
p, p0-DDT 1,1,1-trichloro-2, 2-bis(p-chlorophenyl)-
ethane
DES Diethylstilbestrol




LBW Low birth weight
NCDs Non-communicable diseases
PCB Polychlorinated biphenyls
PPAR Peroxisome proliferator-activated receptor
T2D Type 2 diabetes
Introduction
Non-communicable diseases (NCDs), such as obesity, type
2 diabetes (T2D), and the metabolic syndrome, have long
been believed to stem from factors typifying the way many
people live today, which include an overly high-calorie diet
and low level of physical activity. The obesity epidemic
continues to pose one of the largest worldwide threats to
the health of the population of almost every country in the
world [1, 2]. The metabolic syndrome, a complex condition
linked to obesity that is characterized by a cluster of risk
factors, including hypertension, dyslipidemia, and glucose
intolerance, is also becoming increasingly prevalent [3].
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The reason for the rapid expansion of this epidemic
remains incompletely understood. The recent acceleration
in incidence is too rapid to be accounted for only by
genetics, increases in the caloric density of food, and
declines in physical activity. It is now assumed that envi-
ronmental factors acting early in life, especially during
fetal life, have profound effects on the susceptibility to
disease later in life. Several studies, both in humans and
experimental animals, suggest that altered risk of adult
diseases may be linked to the maternal environmental and
nutritional status around conception and implantation [4,
5]. The observation that early human development affects
the risk of NCDs in later life has been confirmed by epi-
demiological studies [6–8]. Specifically, low birth weight
(LBW) has been associated with increased blood pressure,
dyslipidemia, and impaired glucose metabolism during
adulthood [9–12].
In this review, the concept of the development origins of
health and disease (DOHaD) and its possible underlying
molecular mechanisms are summarized, followed by future
directions for preventive strategies for obesity and T2D in
the public health sector.
Developmental origins of health and disease
The concept of DOHaD is based on the assumption that
environmental factors acting early in life (usually during
fetal life) have profound effects on the predisposition to
disease later in life. The idea that developmental factors
may influence the susceptibility to disease much later in
life was given impetus by a series of epidemiological
studies by Barker et al. [13–18]. These authors reported
that LBW babies who survived infancy and childhood
were at increased risk of having risk factors for coronary
heart disease in adulthood. LBW is considered to be a
marker for an adverse fetal environment and fetal stress.
Correction for known risk factors, such as diet, smoking,
and exercise, did not have a major impact on the rela-
tionships between LBW and subsequent risk of NCDs
[19–23]. Relationships have now been described between
LBW and many risk factors for coronary heart disease,
including hypertension, dyslipidemia, and T2D [24].
LBW has also been associated with increased insulin
resistance later in life [10].
Barker et al. [5, 15] proposed the thrifty phenotype
hypothesis in an attempt to explain the associations
between poor fetal growth and increased risk of obesity and
T2D in adult life. Thrifty genotype confers a survival
advantage in a poor food environment by reducing glucose
uptake and limiting body growth. However, when indi-
viduals of this genotype encounter an environment of
plentiful food, they are at risk of developing obesity and
T2D. This hypothesis can explain the molecular basis of
DOHaD. Since this hypothesis was proposed, many studies
worldwide have provided the epidemiological evidence for
this concept [16, 19–24].
The concept of DOHaD was further supported by the
‘Dutch hunger winter’ studies. The Dutch hunger winter
can be regarded as a unique ‘experiment of history’ and
shows how maternal undernutrition during specific gesta-
tional time windows may affect later health outcome. The
winter of 1944–45 in the Netherlands, which was occupied
by the Germans in May 1940, is known as the ‘hunger
winter.’ Despite the war, nutrition in the Netherlands had
generally been adequate up to October 1944. In October
1944, the German authorities blocked all food supplies to
the occupied west of the Netherlands. These were restored
immediately after liberation on May 5, 1945. Therefore,
children exposed to famine in utero during the hunger
winter were well nourished in childhood and had acceler-
ated weight gain [25]. The hunger winter cohort was used
to examine how maternal undernutrition during specific
gestational time windows affects the subsequent life course
of offspring who experienced the famine in utero.
The results of the studies of the Dutch hunger winter
have given important insights in the causes of DOHaD.
A summary of the study outcomes is provided in Table 1.
The offspring of women exposed to famine in early
gestation, although of normal birth weight, had increased
risk of obesity and a threefold increase in the risk of
coronary heart disease as adults [26, 27]. The offspring of
women exposed to famine in mid- and late gestation were
born smaller than unexposed babies and had an increased
risk of impaired glucose tolerance as adults [28, 29]. In
addition to the studies on the Dutch hunger winter, many
other epidemiological studies have indicated that obesity
and T2D are highly prevalent in subjects born with LBW
[30–34]. The Great Chinese Famine that affected the
Chongqing population during 1959–1961 led to over-
weight females after 50 years [35]. Individuals exposed in
utero and infancy to the Nigerian civil war famine were at
increased risk of obesity and T2D about 40 years later
[36]. Thus, the effects of LBW on the development of
obesity and T2D in adult life have been proven in dif-
ferent studies.
Intriguingly, adverse events during pregnancy not only
affect the offspring of that pregnancy but also the next
generation. Women who were severely undernourished
during the first trimester of pregnancy gave birth to babies
who were of normal birth weight, but those babies them-
selves then went on to give birth to smaller babies in the
next generation [37]. In a cohort of North American Indi-
ans, poor maternal nutrition was reported to be associated
with an increased risk of T2D over several generations
[21].
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Mechanisms of the developmental origins
of metabolic diseases
Although our understanding of the molecular mechanisms
underlying the effects of fetal undernutrition and LBW on
the development of NCDs later in life is far from complete,
possible mechanisms have been proposed. Generally,
organisms possess an evolved ability to respond to external
signals by adjusting their phenotype during development to
match their environment. Thus, poor nutrition of the
pregnant mother may signal to the fetus that nutrients are
scarce in the postnatal environment. Therefore, a fetus that
is exposed to signals it interprets as reflecting nutrient
deficiency or maternal stress will adapt its metabolic
trajectory to suit an environment of limited energy avail-
ability. When the postnatal environment then fails to match
the experienced prenatal environment, maladaptation
occurs, resulting in onset of obesity and T2D [38]. Indeed,
it has been shown that those who were most likely to
develop T2D in adult life had LBW and underwent rapid
postnatal weight gain [39]. In humans, the combination of
LBW and rapid childhood growth has been associated with
later insulin resistance [38, 39]. Recent animal studies have
confirmed that it is mainly the discrepancy between the
pre- and postnatal environments that affects adult onset
diseases, rather than gestational undernutrition itself [40,
41]. The process whereby a stimulus or insult during a
sensitive or critical period has irreversible long-term
Table 1 Studies of the Dutch hunger winter families
Subjects Major findings References
Obesity and type 2 diabetes
Age 19 years Obesity Ravelli et al. [6]
Age 50 years 2-h glucose levels were elevated after a glucose load Ravelli et al. [28]
Increase in body mass index and waist circumference in women Ravelli et al. [26]
Age 58 years 2-h glucose levels were elevated after a glucose load de Rooij SR et al.
[127]
Impaired insulin secretion after a glucose load de Rooij SR et al.
[128]
Glucose intolerance was differed by PPAR-gamma 2 genotype de Rooij SR et al.
[129]
Increased weight and fat deposition in women Stein et al. [130]
No association between prenatal famine and metabolic syndrome de Rooij et al. [131]
Lipid profiles
Age 50 years Increased ratio of low-density to high-density lipoproteins Roseboom et al. [132]
Age 59 years Increased total cholesterol and triglyceride levels in women Lumey et al. [133]
Blood pressure
Age 50 years No differences were found in systolic or diastolic pressure Roseboom et al. [134]
No association with adult blood pressure Roseboom et al. [135]
Age 59 years Moderate increase in systolic but not diastolic blood pressure Stein et al. [136]
Greater blood pressure increase during stress Painter et al. [137]
Atherosclerosis and mortality
Age 50 years Increased prevalence of coronary heart disease in those exposed to the famine in early
gestation
Roseboom et al. [138]
Higher incidence of coronary artery disease Painter et al. [139]
Age 57 years No effect on adult mortality Painter et al. [140]
Reduced carotid artery intima media thickness Painter et al. [141]
Age between 18 and
64 years
Higher overall adult mortality risk in women van Abeelen et al.
[142]
Miscellaneous
Age 24–48 years Increased risk for schizophrenia Susser et al. [143]
Age 50 years Decreased factor VII concentrations Roseboom et al. [144]
Increased prevalence of obstructive airways disease Lopuhaa et al. [145]
Age 58 years No difference in cortisol concentrations after dexamethasone suppression test de Rooij et al. [146]
PPAR Peroxisome proliferator-activated receptor
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effects on development is often referred to as ‘metabolic
programming’ [42].
The stress response may be involved in the pathogen-
esis of DOHaD via the regulation of the hypothalamic–
pituitary–adrenal (HPA) axis, which has potent effects on
metabolism and vasculature [43, 44]. Changes in the HPA
axis have been proposed as a mechanism behind the
epidemiological link between LBW and later increased
blood pressure [45]. Offspring of rat dams given dexa-
methasone during pregnancy have reduced birth weight
and increased blood pressure and glucose intolerance in
adulthood [46, 47]. Intrauterine stress is associated with
insulin resistance and accompanying dysregulation of the
HPA axis, with chronically excessive adrenal glucocorti-
coid secretion and increased stress responses [48].
Mechanistic analysis has shown that intrauterine gluco-
corticoid exposure leads to reduced numbers of gluco-
corticoid receptors in the hypothalamus, resulting in
impaired negative feedback and hence long-term upreg-
ulation of the HPA axis after birth [49]. This, in turn, may
contribute to increased blood pressure and glucose intol-
erance. In humans, exposure to antenatal betamethasone
caused signs of insulin resistance in adult offspring at
30 years of age [50]. Thus, increased maternal cortico-
steroid levels as a result of stress induced by reduced
nutrient availability induce hypertension in the offspring
[51]. A recent study reported that maternal iron restric-
tion, independent of maternal macronutrient or caloric
intake, also works as a fetal stressor that programs met-
abolic and circulatory functions in the offspring [52].
Animal studies are used to clarify the underlying
mechanisms of clinical observations in more detail. Fetal
nutrition is a key regulator of fetal growth and thus an
obvious candidate as an influence on programming [53]. In
fact, rats living in a postnatal obesogenic environment have
very different physiological responses depending on whe-
ther they were born to undernourished or well-fed mothers,
with the former becoming more obese, more hypertensive,
and more hyperphagic than the latter [54]. Imbalance of
protein and carbohydrate intake during pregnancy has been
associated with reduced birth weight and increased blood
pressure in the offspring [55]. Many studies have shown
that prenatal protein restriction results in LBW and pro-
grams hypertension in experimental animals [56–58].
Embryos collected from mothers fed a low-protein diet
have reduced cell numbers [59]. In particular, a strong
correlation has been found between nephron number and
birth weight [60], and a reduction in nephron number is
associated with increased blood pressure [61]. Exposure of
rats to a low-protein diet in utero also decreases b-cell
proliferation, islet size, and islet vascularization [62].
Subsequent accelerated growth leads to an excessive met-
abolic demand on this limited cell mass.
Transcriptome-wide analysis using the Affymetrix
Mouse 430A_2.0 array (Affymetrix, Santa Clara, CA)
showed that feeding mice a protein-restricted diet between
gestational days 10.5 and 17.5 altered the expression of 235
genes in the placenta [63]. In the adult male offspring of
dams fed a protein-restricted diet, 311 genes in the liver
differed significantly from those in the offspring of control
dams, as determined by the Agilent 014879 whole rat
genome array (Agilent Technologies, Santa Clara, CA)
[64]. Thus, an altered maternal diet during pregnancy
induces persistent changes in the transcriptome. Whatever
the mechanisms, these events may occur in humans if
undernutrition in utero is followed by an abundant post-
natal diet, such in small babies born into a food-rich
Western society.
Role of epigenetics
The induction of altered phenotypes during development in
response to environmental stimuli involves epigenetic
changes. Epigenetic regulation has been defined as ‘‘heri-
table changes in gene function that occur without changes
in the nucleotide sequence’’ [65]. Epigenetic factors
include DNA methylations, histone modifications, and
microRNAs. Epigenetic changes, in particular in DNA
methylation, provide a ‘memory’ of developmental plastic
responses to the early environment and are central to the
generation of phenotypes and their stability throughout the
life course. Methylation at the 50 position of cytosine in
DNA within a CpG dinucleotide (the p denotes the inter-
vening phosphate group) is a common modification in
mammalian genomes and constitutes a stable epigenetic
mark that is transmitted through DNA replication and cell
division [66]. CpG dinucleotides are not randomly dis-
tributed throughout the genome but are clustered at the 50
ends of genes/promoters in regions known as CpG islands.
Hypermethylation of these CpG islands is generally asso-
ciated with transcriptional repression, while hypomethyla-
tion of CpG islands is generally associated with
transcriptional activation.
Data from animal models suggest that epigenetic pro-
cesses are an important link between the early life envi-
ronment and altered metabolism and body composition in
the adult offspring [67, 68]. A growing body of literature
has reported a role for epigenetic factors in the complex
interplay between genes and the environment [4, 69–71].
Epigenetic changes may explain how an altered maternal
diet during pregnancy, such as a protein restricted diet,
induces persistent changes in the transcriptome.
Environmental developmental influences, such as the
maternal diet or chemical exposure, can affect the offspring
phenotype via epigenetic effects [72, 73]. A diet that is poor
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or enriched in methyl donors and cofactors of DNA meth-
ylation, especially during fetal growth and development,
may influence the epigenotype. For example, a methyl-rich
maternal diet during gestation was found to alter the body
composition of the offspring in agouti mice, which was
accompanied by epigenetic changes in metabolic control
genes [74]. Thus, environmentally induced epigenetic
modifications alter gene expression and may increase the
offspring’s susceptibility for later disease [75, 76].
It has been shown in rodent models that unbalanced
maternal diets during pregnancy induce changes in DNA
methylation and covalent histone modifications in the 50
regulatory regions of specific non-imprinted genes,
affecting the offspring’s later body composition and met-
abolic phenotype [77, 78]. For example, the offspring of rat
dams fed a protein-restricted diet had lower levels of CpG
methylation and greater expression of the peroxisome
proliferators-activated receptor (PPAR) a and glucocorti-
coid receptor (GR) genes in the liver than control animals
[77]. Changes in the epigenetic regulation of these genes
may result in alterations in the activity of pathways con-
trolled by their target genes, such as phosphoenolpyruvate
carboxykinase and acyl-CoA oxidase, which subsequently
affects lipid and carbohydrate metabolism. Hypomethyla-
tion of the hepatic PPARa and GR promoters has been
reported in both F1 and F2 offspring of F0 rats fed a pro-
tein-restricted diet during pregnancy without further
nutritional challenge to the F1 generation, indicating that
changes in the epigenome that occur during development
may be passed on to subsequent generations [68].
Intrauterine growth restriction has been associated with
progressive epigenetic silencing of Pdx1, a pancreatic and
duodenal homeobox 1 transcription factor critical for b-cell
development, resulting in impaired b-cell function and
T2D in the adult offspring in rats [79]. Lack of methylation
of the retrotransposon with a methylation-sensitive pro-
moter was associated with subsequent offspring obesity in
mice [80]. In contrast, supplementation of the diets of
pregnant animals with methyl donors, such as folic acid,
vitamin B12, choline, or betaine, increased DNA methyl-
ation of specific genes in the offspring [74, 81–83].
Overall, these results show that dietary modifications can
induce altered phenotypes through epigenetic changes in
specific genes and that these changes in phenotype can be
modulated by nutritional interventions during pregnancy.
As yet there are limited published human data linking
maternal nutrition to epigenetic changes in the offspring.
Adults who were exposed to famine in utero showed
altered DNA methylation in the promoters of several
imprinted and non-imprinted genes in white blood cells.
Two studies on the Dutch hunger winter families reported
the effects of prenatal undernutrition on promoter methyl-
ation [84, 85]. Individuals with periconceptual exposure to
famine had reduced DNA methylation of the imprinted
insulin-like growth factor-2 (IGF2) gene, a key factor in
human growth and development, as compared with their
unexposed, same-sex siblings at 59 years of age [84]. In
addition, individuals from Dutch hunger winter families
also had lower DNA methylation of the imprinted INS-
IGF2 (INSIGF) gene, but increased DNA methylation of
the guanine nucleotide-binding protein (GNASAS), mater-
nally expressed 3 (MEG3), interleukin-10 (IL10), ATP-
binding cassette A1 (ABCA1), and leptin (LEP) genes in
parallel with impaired glucose tolerance compared with
their unexposed same-sex siblings [85]. A recent study
reported that higher methylation of retinoid X receptor-a
chr9 was associated with lower maternal carbohydrate
intake in early pregnancy, which is also associated with
higher neonatal adiposity [53]. Thus, it is clear that fetal
stress can affect the methylation status of several subsets of
genes, supporting the hypothesis that associations between
early developmental conditions and health outcomes later
in life may be mediated by changes in the epigenetic
information. However, the differences in methylation sta-
tus of these genes between the exposed and unexposed
individuals were relatively small, although statistically
significant. Further studies with clear end points are needed
to determine whether measurement of epigenetic marks in
early life can be used as biomarkers to identify individuals
who have experienced environmental perturbations in
development and thus who are more likely to develop
obesity and metabolic disease in later adulthood. It is
crucial to identify such epigenetic marks that are predictive
of a later phenotype so that they can be used as relevant
biomarkers for disease prevention.
Role of chemicals
Because the obesity epidemic coincided with the rapid
increase in the use of industrial chemicals, the hypothesis
that exposure to chemicals, combined with genetic pre-
disposition and consumption of a high-calorie diet, may be
a major contributor to the obesity epidemic was proposed
nearly 10 years ago [86, 87]. Since then, a number of
studies have specifically addressed the effects of environ-
mental chemical exposure on weight gain. Chemicals that
affect human fetal development are generally called
endocrine-disrupting chemicals (EDCs). EDCs are com-
pounds that act upon the body’s hormonal systems and
include industrial contaminants, plastics, pesticides, and
other compounds [88]. EDC contamination is a global
problem. Bisphenol A (BPA), the prototypical EDC, is
produced in large quantities for use in the production of
polycarbonate and epoxy resins. However, when used in
food and drink containers, it can ‘leach’ into the contents,
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resulting in ingestion of BPA with food and drink [89]. As
a result, human exposure to BPA is widespread, and BPA
has been detected in urine in more than 90 % of all human
samples tested [89, 90]. Some EDCs are highly resistant to
degradation and remain persistent in the environment. For
example, persistent organic pollutants, which include
polychlorinated dibenzo-p-dioxins, polychlorinated dib-
enzofurans, and polychlorinated biphenyls (PCBs) can
accumulate in the human body, especially in adipose tissue
because of their lipophilic nature. Although the production
of PCBs was banned by the USA in the 1970s, PCBs
remain ubiquitous contaminants in the human population
even today because of their stability [91]. Many studies
have been conducted to study the link between chemical
exposure and metabolic disorders. The findings of studies
on the effects of environmental chemicals on obesity and
T2D are summarized in Table 2.
Epidemiological studies on maternal smoking have
indicated that the adjusted odds ratio for obesity is between
1.5- and 2.0-fold greater if children were exposed during,
but not before or after, pregnancy [92–94], suggesting that
there are critical periods during embryogenesis when the
embryo is the most sensitive to exposure to xenobiotics.
These studies also indicated that chemical toxicants, such
as nicotine, can contribute to the etiology of later obesity.
In humans, there is epidemiological evidence for the
association between developmental exposure to chemicals
and metabolic disorders later in life [95]. It has been
demonstrated that chemicals cross the placenta and directly
affect the fetus [96]. Maternal exposure to chemical sub-
stances during pregnancy has been associated with an
increased body mass index (BMI) in the offspring [97–99].
Several studies have indicated that organochlorine expo-
sure may be associated with the development of T2D [97,
98, 100–103]. For example, the results of a Spanish cohort
study showed that prenatal exposure to the organochlorine
hexachlorobenzene was associated with increased BMI at
age 6 years [97]. Prenatal exposure to dichlorodiphenyl-
dichloroethylene (DDE) was significantly associated with
increased weight and BMI in adult female offspring [98].
DDE in cord blood was associated with increased BMI in
young children, and this effect was exacerbated by
maternal smoking [103]. A recent prospective study
reported that in utero exposure to perfluorooctanoate was
positively associated with risk of overweight at age 20
years in female but not in male offspring [104]. Collec-
tively, these results support the hypothesis that the fetus is
vulnerable to exposure to environmental chemicals,
resulting in an increased risk of excessive body weight gain
and susceptibility to T2D later in life. Moreover, gender
and the postnatal environment in combination with prenatal
chemical exposure can modify the onset, as well as the
progression and outcome of the disease.
In experimental cell cultures and animal studies, a
variety of chemicals have been shown to act as adipogen-
esis or obesity-inducing agents. A number of chemicals are
known to promote obesity by increasing the number of
adipocytes or the storage of fat into existing adipocytes.
The organochlorine compound 1, 1, 1-trichloro-2, 2-bis
(p-chlorophenyl)-ethane (p, p0-DDT) induces a concentra-
tion-dependent increase in in vitro 3T3-L1 adipocyte dif-
ferentiation [105]. In mouse studies, treatment with the
synthetic estrogen diethylstilbestrol (DES) on days 1–5 of
neonatal life at 0.001 mg/day increased body weight and
the percentage of body fat [106]. Treatment of pregnant
mice with xenoestrogen BPA resulted in increased body
weight in the female offspring on postnatal day 22 com-
pared with unexposed controls [107]. Recent studies have
indicated that perinatal exposure to approximately 70 lg/
kg/day BPA via drinking water alters early adipogenesis
and increases body weight in rodent models [108, 109].
Mice perinatally exposed to DES or the phytoestrogen
genistein increased weight after puberty [106, 110, 111].
Wright et al. [112] reported that exposure to octylphenol,
another xenoestrogen, during fetal and postnatal life in
female lambs led to increased weight at puberty. During
development, estrogen induces an increase in adipocyte
numbers and affects adipocyte function [113]. Overall,
these results show that exposure to organochlorine com-
pounds and/or xenoestrogens during sensitive windows of
development may have obesogenic effects, and may lead to
permanent changes in the metabolic pathways that regulate
body weight.
Other chemicals that can work as potential obesogens
are the organotins. Organotins represent a class of persis-
tent organic pollutants that may reach harmful levels in
exposed populations [114]. In culture systems, organotins
induce adipocyte differentiation [115, 116]. Tributyltin is
also known to induce adipogenesis in vivo. Mice treated
prenatally with tributyltin are born with more stored fat
than controls [117]. Multipotent stromal cells harvested
from white adipose tissue at 8 weeks of age in mice pre-
natally exposed to tributyltin had high numbers of preadi-
pocytes and cells preprogrammed to prefer the adipogenic
fate, an effect that will likely lead to an increase in adipose
mass over time [118]. Organotins work via direct activation
of the PPARc–retinoid X receptor (RXR) heterodimer
[116]. Activation of the PPARc–RXR heterodimer has
been found to favor lipid biosynthesis and storage, and
induces adipocyte differentiation. Interestingly, a recent
report indicated that tributyltin can work as a xenoestrogen
via estrogen receptors in vivo [119]. Among commonly
used phthalates as plasticizers, monoethyl-hexyl-phthalate
can work as an activator for PPARc [120].
The mechanisms of action of these chemicals are diverse
and probably involve epigenetic molecular changes,
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Table 2 Studies on environmental chemicals on obesity and type 2 diabetes
Subjects Chemicalsa Major findings References
Human studies
Adults in southern Taiwan Arsenic High prevalence of T2D Lai et al. [147]
Air Force veterans TCDD Increased prevalence of T2D Henriksen et al. [148]
Air Force veterans TCDD Serum level was correlated with incidence of
T2D
Longnecker et al. [149]
Pubertal boys DDE Increased body weight Gladen et al. [150]
Adults POPs Correlated with the prevalence of T2D Lee et al. [100]
Adult women PCB Increased incidence of T2D Vasiliu et al. [102]
Mexican Americans p, p0-DDT Increased prevalence of T2D Cox et al. [151]
Adult native Americans HCB Serum level was positively correlated with
incidence of T2D
Codru et al. [152]
U.S. population Organochlorine pesticides Positively associated with metabolic syndrome Lee et al. [153]
Children aged 6 years HCB Increased BMI (body mass index) and body
weight
Smink et al. [97]
Yucheng poisoning women PCBs Increased prevalence of T2D Wang et al. [95]
Residents in Cd-contaminated area Cd Correlated with diabetic nephropathy Hanswell-Elkins et al. [154]
Air Force veterans TCDD Increased prevalence of T2D Michalek et al. [155]
Adult female offspring DDE Increased weight and BMI Karmaus et al. [98]
Women aged 50–59 years p, p0-DDE Increased prevalence of T2D Rignell-Hydbom et al. [156]
Workers PFOS Increased prevalence of T2D Lundin et al. [157]
Children aged 3 years DDE and PCBs Intrauterine exposure was associated with BMI Verhulst et al. [103]
Great Lakes sport fish consumers DDE Increased incidence of T2D Turyk et al. [158]
Women in southern Spain Nonylphenol Positively associated with BMI Lopez-Espinosa et al. [159]
Adults of eastern Slovakia PCBs Increased prevalence of T2D Ukropec et al. [160]
Koreans Organochlorine pesticides Increased prevalence of T2D Son et al. [161]
Adults PCBs Increased prevalence of T2D Lee et al. [162]
Koreans Heptachlor epoxide Positively associated with metabolic syndrome Park et al. [163]
Children at 14 months DDE Elevated BMI Mendez et al. [164]
Adults aged 18–74 BPA Higher exposure was associated with general
and central obesity
Carwile et al. [165]
Women aged 20 years PFOA Maternal PFOA concentrations were positively
associated with BMI
Halldorsson et al. [104]
Adult populations of Catalonia PCBs and HCBs Positively associated with diabetes and
prediabetes
Gasull et al. [166]
Animal studies
Rats Cd Neonatal exposure increased diabetic prevalence Merali et al. [167]
Female mice BPA Perinatal exposure led to obesity Howdeshell et al. [107]
Female rats BPA Perinatal exposure led to obesity Rubin et al. [168]
Rats BPA Perinatal exposure led to impaired glucose
tolerance
Wei et al. [109]
Female ewe lambs Octylphenols Gestational exposure led to obesity Wright et al. [112]
Mice DES Perinatal exposure led to obesity Newbold et al. [106]
Mice TBT In utero exposure led to obesity Grun et al. [117]
Female mice BPA Perinatal and postnatal exposure led to obesity Miyawaki et al. [169]
Female mice PFOS Work as developmental obesogen Hines et al. [170]
Female rats BPA Gestational exposure led to obesity Somm et al. [108]
Mice TBT In utero exposure led to multipotent stem cells to
become adipocytes
Kirchner et al. [118]
TD2 Type 2 diabetes, BMI body mass index
a TCDD 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin, DDE dichlorodiphenyl-dichloroethylene, POPs persistent organic pollutants, PCB polychlorinated
biphenyl, p, p0-DDT dichlorodiphenyltrichloroethane, HCB hexachlorobenzene, Cd cadmium, PFOS perfluorooctanesulfonic acid, BPA bisphenol A,
PFOA perfluorooctanoate, DES diethylstilbestrol, TBT tributyltin, PFOS perfluorooctanoic acid
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including DNA methylation and histone modifications
[121]. Environmental compounds may induce the estab-
lishment of specific epigenetic patterns during key devel-
opmental periods that influence phenotypic variation,
which in some cases lead to disease states [122, 123].
Indeed, maternal exposure to BPA decreased DNA meth-
ylation in the retrotransposon upstream of the agouti gene
in mice and shifted coat color distribution in the offspring
by stably altering the epigenome [74]. Whatever the
mechanism, complex events, including exposure to obes-
ogenic or diabetogenic chemicals during development, may
be contributing to the obesity and T2D epidemics. Clari-
fying the mechanisms involved in weight homeostasis is a
novel target in the study of abnormal programming induced
by environmental chemicals, which should be re-named
‘metabolic disrupting chemicals’ [124].
Future perspectives
We are in the midst of a global epidemic of obesity with
substantial negative health and socio-economic conse-
quences. There is now growing evidence that develop-
mental influences have lifelong effects on metabolic
function (Fig. 1). Perturbations of the developmental milieu
can have a profound impact on the onset and incidence of
obesity and T2D. Phenotypic outcomes with long-term
consequences involve the interplay between environmental,
developmental, and genetic influences. The pathogenesis of
obesity and T2D resides in a mixture of genetic and envi-
ronmental factors. It is therefore probable that not only
maternal nutrition and stress, but also maternal size, parity,
and maternal age can affect the offspring phenotype and/or
epigenetic states. Moreover, possible interplay among pre-
natal exposure and the postnatal environmental factors,
such as nutrition, stress, chemical exposure, and aging, can
affect disease outcome. Further studies are merited to
clarify the interactions that mediate metabolic outcomes.
Transient environmental conditions during human ges-
tation can be recorded as persistent changes in the epige-
nome. Epigenetic changes, in particular those in DNA
methylation, are central to the generation of novel pheno-
types and their stability throughout the life course. In the
future, epigenetic research may have substantial benefits
for public health because specific components of the epi-
genetic state at birth may predict later obesity and T2D.
Researchers need to identify such effective epigenetic
biomarkers which can be measured at early stage of life.
These epigenetic marks may be important biomarkers,
which not only indicate responses to prenatal challenges,
but also predict later risk for obesity and T2D. Current
studies are limited to analyzing specific candidate loci, and
the complete epigenome has yet to be explored. New
technologies, such as methods for rapid sequencing for
differentially methylated regions of the genome, need to be
developed before large-scale epidemiological studies can
be conducted. It is likely that comprehensive studies of the
epigenome will be helpful to shed light on gene–environ-
ment interactions in the pathogenesis of obesity and T2D.
Accumulating data indicate that low doses of environ-
mental chemicals have adverse effects on human health
[125]. These days, individuals are exposed to a mixture of
EDCs. Indeed, dozens of environmental chemicals are
detected in human tissues and fluids [126]. However, very
little is known about how these chemicals act in combi-
nation. So far, almost all epidemiological studies have
looked for the associations between metabolic disorders
and the exposure to a single EDC at a single time, rather
than to the whole mixture of toxicants to which human are
exposed. These mixtures are likely to have unexpected and
unpredictable effects. Further prospective studies with











Fig. 1 Influences during critical fetal periods may cause the adult onset of non-communicable diseases, such as obesity and type 2 diabetes
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exposure to mixtures of EDCs in early life can influence
the development of obesity and T2D.
NCDs are preventable, but new initiatives are needed to
institute prevention. If the risk of many common diseases
of adulthood in our communities is largely determined
before birth, adult lifestyle interventions will only reduce
the risk transiently or to a small degree because they occur
too late. Thus, from a public health perspective, it is
important to determine whether interventions after the
neonatal period can reverse the adverse effects of unbal-
anced prenatal nutrition. If the effects of adult lifestyle
interventions are limited, maximum effect will be gained
from timely interventions in early life. Improved nutrition
will not only benefit the present population but may also
reduce disease in future generations. If so, more care
should be given to the consumption of a healthy diet during
pregnancy and improved fetal nutrient availability, which
may lead to a more normal birth weight and early life
growth, thereby reducing the risk for programmed meta-
bolic disease. Clear evidence and good communication of
this evidence may lead to policy responses that will open
the possibility of nutritional or pharmacological interven-
tions to combat the rapid rise in obesity and T2D.
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